Kevin Donnelly, MD
Dermatology · Westerville, OHNPI 1366805517
Payments from drug & device makers
Across 714 payments — averaging $493.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$212K
- Sanofi US Services Inc.$69K
- Incyte Corporation$61K
- AbbVie$4K
- Johnson & Johnson$1K
- E.r. Squibb & Sons, L.L.C.$888
- plus $6K from 26 others
Across 11 payments — averaging $652.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$6K
- AbbVie$1K
What the payments were for
- Consulting fees$2,40017%
- Food & beverage$11,58381%
- Education$3522%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 141 | $212,121 |
| Sanofi US Services Inc. | 15 | $68,612 |
| Incyte Corporation | 77 | $60,666 |
| AbbVie | 155 | $3,519 |
| Johnson & Johnson | 45 | $1,023 |
| E.r. Squibb & Sons, L.L.C. | 38 | $888 |
| Regeneron Healthcare Solutions, Inc. | 30 | $690 |
| Lilly USA, LLC | 32 | $608 |
| Journey Medical Corporation | 8 | $587 |
| Pfizer | 38 | $502 |
| Dermavant Sciences, Inc. | 16 | $409 |
| Sanofi | 10 | $337 |
| Sun Pharmaceutical Industries Inc. | 17 | $329 |
| Boehringer Ingelheim | 11 | $258 |
| Galderma Laboratories, L.p. | 12 | $246 |
| Novartis | 7 | $233 |
| Organon | 7 | $205 |
| Mayne Pharma Commercial LLC | 9 | $196 |
| Almirall LLC | 10 | $193 |
| Amgen | 13 | $193 |
| Mallinckrodt Enterprises LLC | 1 | $183 |
| VYNE Pharmaceuticals Inc. | 1 | $125 |
| Stemline Therapeutics Inc. | 1 | $120 |
| Merck | 1 | $112 |
| UCB, Inc. | 4 | $79 |
| Arcutis Biotherapeutics, Inc. | 4 | $57 |
| Botanix SB Inc | 2 | $55 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $35 |
| Genentech USA, Inc. | 2 | $34 |
| LEO Pharma Inc. | 2 | $32 |
| Biofrontera Inc. | 2 | $29 |
| Kyowa Kirin, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$352,699 in reported general payments places this provider in the 90th percentile of 460 dermatology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 12 | $81,404 |
| Doxycycline Hyclate | 20 | $2,544 |
| Fluorouracil | 20 | $1,915 |
| Clobetasol Propionate | 57 | $1,614 |
| Dapsone | 11 | $1,187 |
| Triamcinolone Acetonide | 85 | $692 |
| Ketoconazole | 62 | $618 |
| Metronidazole | 13 | $603 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 14 | $343 |
| Fluocinonide | 11 | $321 |
| Mupirocin | 22 | $125 |
| Hydrocortisone | 40 | $115 |
| Cephalexin | 17 | $61 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Westerville
- Jennifer NashWesterville$4M
- Jess DemariaWesterville$813K
- Joshua GrosshandlerWesterville$479K
- Matthew ZirwasBexley$7.4M
- Neil KormanCleveland$6M
- Jeffrey TraversDayton$4.7M
- Jessica KaffenbergerColumbus$3.2M
- Rocco SerraoDayton$3M
- Patrick ShannonBoardman$2M
- George DrewMarion$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.